KC

Kieran Chacko

Founder of Ambrosia Biosciences Inc.

Cambridge, Massachusetts

Overview 

Kieran Chacko is a biotechnology entrepreneur and scientist currently serving as the Executive Vice President of Data Science & Strategy at Harbinger Health in Cambridge, Massachusetts. With a background in leading data science and strategy teams, Chacko has been a key player in the founding and growth of innovative biotechnology companies like Ambrosia Biosciences Inc. and has held significant roles at Flagship Pioneering, contributing to the advancement of the health and hospital services sector.

Work Experience 

  • Executive Vice President of Data Science & Strategy

    2024 - Current

  • Head Data Science & Strategy

    2021 - 2024

  • Founding Team

    2019 - 2021

Harbinger Health is a biotechnology company that develops a two-tier testing model for the detection of early cancer with a blood test.

Raised $190,000,000.00 from Pictet Private Equity Investors S.A., M&G Investments, Flagship Pioneering, Partners Investment, Catalyst and Modi Ventures.

  • Co-Founder & Strategic Advisor

    2024

Ambrosia Biosciences offers drug development services for small molecule-based therapies for obesity and other metabolic disorders.

Raised $16,000,000.00 from Biotechnology Value Fund and Boulder Ventures.

  • Principal

    2023 - 2024

  • Senior Associate

    2021 - 2023

  • Associate

    2019 - 2021

Flagship Pioneering is a venture capital firm that invests in life sciences and healthcare companies.

  • Fellow

    2018 - 2018

Flagship Pioneering is a venture capital firm that invests in life sciences and healthcare companies.

  • Analyst

    2012 - 2014

J.P. Morgan Ventures Energy Corporation provides commodity risk management solutions in both the physical .

  • Summer Analyst

    2011 - 2011

J.P. Morgan Ventures Energy Corporation provides commodity risk management solutions in both the physical .

Articles About Kieran

Relevant Websites